Genética Laboratorios is a subsidiary of Grupo Amaya Curiel, a Mexican corporation based in Baja California with over four decades of operations in various industries in the region. With 27 years of experience, they specialize in the production of high-quality generic drugs that make healthcare accessible to families with safety and efficacy. Their expertise lies in the manufacturing and conditioning of pharmaceutical products in various dosage forms, such as tablets and hard gelatin capsules.
Genética Laboratorios' business lines include the capacity for dry and wet processing, development of proprietary brands, and hosting. Their vision is to be a benchmark in the production of high-quality generic drugs in Mexico and to be recognized for the reliability of their products. Located close to the California border, 40 kilometers from Tijuana Airport, their strategic positioning is advantageous for their operations. Additionally, they have a distribution center in Mexico City.
Founded in 1994, Genética Laboratorios operates within the manufacturing and pharmaceutical industries. Despite the lack of publicly available information on their last investment and investors, the company's longstanding presence and commitment to quality in the pharmaceutical sector make it an interesting prospect for potential investors.
There is no investment information
No recent news or press coverage available for Genética Laboratorios.